Reteplase: a review of its use in the management of thrombotic occlusive disorders.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Volumn 6, Issue 4, 2006, Pages 265-285

  Simpson, Dene ^a   Siddiqui, M Asif A ^a   Scott, Lesley J ^a   Hilleman, Daniel E ^a  

^a ADIS INTERNATIONAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; RETEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HEART INFARCTION; HUMAN; LUNG EMBOLISM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; REVIEW; THROMBOSIS;

ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; PULMONARY EMBOLISM; RECOMBINANT PROTEINS; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 39049176482     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200606040-00007     Document Type: Review

References (136)